Evidence map›Paper›PMID 33097069›Full record

ArticleDiagnostic pathology2020

Gastric adenocarcinoma of the fundic gland type: clinicopathological features of eight patients treated with endoscopic submucosal dissection.

Chengfang Li, Xinglong Wu, Shuang Yang, Xiaorong Yang, Jin Yao, Hong Zheng

Abstract read
In one paragraph

Article in Diagnostic pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Feasibility study of cap-assisted endoscopic mucosal resection for gastric adenocarcinoma of fundic gland type.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Gastric adenocarcinoma of the fundic gland type: A review of the literature.JGH open : an open access journal of gastroenterology and hepatology · 2023
    Review
  8. Endoscopic Resection for Gastric Adenocarcinoma of the Fundic Gland Type: A Case Series.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2023
    Article
  9. Observational
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chengfang LiDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Guizhou, 563003, China.ORCID http://orcid.org/0000-0001-5018-9495
Xinglong WuDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Guizhou, 563003, China.
Shuang YangDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Guizhou, 563003, China.
Xiaorong YangDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Guizhou, 563003, China.
Jin YaoDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Guizhou, 563003, China.
Hong ZhengDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Guizhou, 563003, China. zhenghonghq@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastric adenocarcinoma of the fundic gland type (GA-FG) has been added to the 2019 edition of the World Health Organization's list of digestive system-associated cancers. This lesion differentiates toward the fundic gland and mostly involves chief cell-predominant differentiation with low-grade cytology. Clinicians and pathologists are still unaware of this rare disease; consequently, some cases are incorrectly diagnosed. This study aimed to investigate the clinicopathological features of GA-FG using retrospective analyses of endoscopic and pathological findings. MATERIALS AND

methodsSamples were collected from patients diagnosed with GA-FG. The clinical courses of all patients were monitored prospectively and reviewed retrospectively. Available clinical information, endoscopic features, pathological appearance, and follow-up data were assessed. Immunohistochemistry [mucin (MUC) 2, MUC5, MUC6, P53, CDX2, Ki67, SYN, CD56, CGA, β-catenin, and pepsinogen-I] was examined using Envision two-step method.

resultsEight cases of endoscopic submucosal dissection (ESD) were obtained from our institution. Patient age ranged from 48 to 80 years (mean, 65 years). Some patients were on acid-suppressing medication. Most lesions were located in the upper third (n = 7) and one was in the middle third of the stomach. Six lesions were of the superficial flat type, whereas two were of the superficial elevated type. Narrow-band imaging using magnifying endoscopy showed irregular microvascular patterns (MVPs) in four cases and regular MVPs in the remaining cases. All lesions were primarily solitary and ~ 6 mm in diameter (largest, 12 mm). The main body of the tumors were localized in the mucosal layer, of which six cases invade into the submucosal layer. Well-formed glands of chief cells were predominant. Tumor cells were positive for pepsinogen-I, MUC6, SYN, and CD56. Lymphatic and vascular infiltration and metastatic and recurrent disease were not observed in any case.

conclusionGA-FG, a well-differentiated adenocarcinoma with mild atypia, can be completely removed using ESD, with a favorable prognosis in patients.

Indexed as

AdenocarcinomaAgedAged, 80 and overEndoscopic Mucosal ResectionFemaleGastric FundusHumansMaleMiddle AgedStomach NeoplasmsChief cellsEndoscopic diagnosisEndoscopic submucosal dissectionGastric adenocarcinoma of the fundic gland typePathological diagnosisPepsinogen-I

Identifiers

PMID33097069
PMCPMC7585219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.